HAP Trading’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-100,000
Closed -$9.34K 1162
2023
Q4
$9.34K Buy
+100,000
New +$1.99M ﹤0.01% 706
2022
Q2
Sell
-10,700
Closed -$5K 2467
2022
Q1
$5K Buy
+10,700
New +$59.2K ﹤0.01% 1956
2019
Q2
Sell
-18,300
Closed -$22K 1376
2019
Q1
$22K Buy
+18,300
New +$79.3K ﹤0.01% 815
2018
Q3
Sell
-16,500
Closed -$5K 1216
2018
Q2
$5K Sell
16,500
-164,000
-91% -$1.73M ﹤0.01% 923
2018
Q1
$129K Buy
+180,500
New +$1.78M 0.01% 512
2015
Q3
Sell
-32,000
Closed -$2K 1221
2015
Q2
$2K Sell
32,000
-500
-2% -$5.49K ﹤0.01% 941
2015
Q1
$23K Buy
+32,500
New +$235K ﹤0.01% 703

Other funds holding IMGN

HAP Trading's IMGN Position: Q3 2023 in Review

HAP Trading sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 17,995 shares — an estimated $340K sold.

HAP Trading first reported a position in IMGN in Q2 2023 and held it in 1 quarter. The position peaked at $340K in Q2 2023. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

  • HAP Trading reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
  • HAP Trading sold 17,995 Immunogen Inc shares in Q3 2023, an estimated $340K.
  • HAP Trading first reported a position in Immunogen Inc in Q2 2023 and held it in 1 quarter.
  • HAP Trading's Immunogen Inc position peaked at $340K in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on HAP Trading's 13F filing for Q3 2023, filed 9 Nov 2023.